These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23129730)

  • 1. Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy.
    Andréjak C; Almeida DV; Tyagi S; Converse PJ; Ammerman NC; Grosset JH
    J Antimicrob Chemother; 2013 Mar; 68(3):659-65. PubMed ID: 23129730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro sensitivity of Mycobacterium xenopi to five antibiotics.
    Dauendorffer JN; Laurain C; Weber M; Dailloux M
    Pathol Biol (Paris); 2002 Dec; 50(10):591-4. PubMed ID: 12504367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations.
    Andréjak C; Almeida DV; Tyagi S; Converse PJ; Ammerman NC; Grosset JH
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2129-35. PubMed ID: 25624335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nontuberculous mycobacterial pulmonary disease - The new ATS/ERS/ESCMID/IDSA Guideline].
    Wagner D; Lange C
    Dtsch Med Wochenschr; 2020 Aug; 145(16):1145-1151. PubMed ID: 32791550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal and sterilizing activities of several orally administered combined regimens against Mycobacterium ulcerans in mice.
    Ji B; Chauffour A; Robert J; Jarlier V
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1912-6. PubMed ID: 18391038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.
    Ferro BE; van Ingen J; Wattenberg M; van Soolingen D; Mouton JW
    J Antimicrob Chemother; 2015 Oct; 70(10):2838-43. PubMed ID: 26142475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice.
    Lounis N; Truffot-Pernot C; Bentoucha A; Robert J; Ji B; Grosset J
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3229-30. PubMed ID: 11600387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
    Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
    PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Mycobacterium xenopi infection in AIDS patients treated with HAART in Hungary.
    Szlávik J; Sárvári C
    Eur J Clin Microbiol Infect Dis; 2003 Nov; 22(11):701-3. PubMed ID: 14557921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
    Al Jarad N; Demertzis P; Jones DJ; Barnes NC; Rudd RM; Gaya H; Wedzicha JA; Hughes DT; Empey DW
    Thorax; 1996 Feb; 51(2):137-9. PubMed ID: 8711643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report].
    Gochi M; Kaneko Y; Seki A; Saitou Z; Samejima T; Seki Y; Takeda H; Kinoshita A; Kuwano K
    Kekkaku; 2012 Nov; 87(11):733-6. PubMed ID: 23367833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
    Andréjak C; Lescure FX; Schmit JL; Jounieaux V
    Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin.
    Schmitt H; Schnitzler N; Riehl J; Adam G; Sieberth HG; Haase G
    Clin Infect Dis; 1999 Jul; 29(1):120-4. PubMed ID: 10433574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection.
    Manfredi R; Nanetti A; Morelli S; Ferri M; Valentini R; Calza L; Chiodo F
    HIV Clin Trials; 2004; 5(4):206-15. PubMed ID: 15472795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolongation of incubation time improves clinical diagnosis of Mycobacterium xenopi infection and allows susceptibility testing of mycobacterial strains against multiple antibiotics.
    Cento V; Nava A; Lepera V; Torri S; Colagrossi L; Fanti D; Vismara C; Perno CF; Mazzola E
    J Glob Antimicrob Resist; 2020 Sep; 22():533-537. PubMed ID: 32387259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report.
    Okano Y; Shinohara T; Imanishi S; Takahashi N; Naito N; Taoka T; Kadota N; Ogushi F
    BMC Pulm Med; 2016 Jun; 16(1):92. PubMed ID: 27287608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment.
    Jenkins PA; Campbell IA;
    Respir Med; 2003 Apr; 97(4):439-44. PubMed ID: 12693807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nontuberculous Mycobacterial Pulmonary Disease - The New ATS/ERS/ESCMID/IDSA Guideline].
    Wagner D; Lange C
    Pneumologie; 2020 Nov; 74(11):773-779. PubMed ID: 33202438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation.
    Salmon JH; Direz G; Ziza JM; Desplaces N; Brochot P; Eschard JP
    Joint Bone Spine; 2012 Jul; 79(4):409-11. PubMed ID: 22405857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.